Mark N. Stein
Impact in
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Prostate Cancer Treatment and Research 59
- Renal cell carcinoma treatment 37
- Oncology 113
- Cancer Immunotherapy and Biomarkers 57
- Cancer Treatment and Pharmacology 21
- Co-authors
- Robert S. DiPaola (45 shared papers)Eileen White (11 shared papers)Susan Goodin (12 shared papers)Kevin Bray (4 shared papers)Grace L. Lu‐Yao (5 shared papers)Charles G. Drake (16 shared papers)Yu‐Hsuan Joni Shao (4 shared papers)Simantini Eddy (5 shared papers)
- Journals
- Journal of Clinical Oncology (111 papers)Clinical Cancer Research (9 papers)Annals of Oncology (8 papers)Cancer Research (8 papers)Investigational New Drugs (7 papers)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Mark N. Stein
236 papers receiving 5.9k citations
Mark N. Stein's Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 2.0k
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 1.8k
- Immunology 811
- Molecular Biology 2.0k
Countries citing papers authored by Mark N. Stein
This map shows the geographic impact of Mark N. Stein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark N. Stein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark N. Stein more than expected).
Fields of papers citing papers by Mark N. Stein
This network shows the impact of papers produced by Mark N. Stein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark N. Stein. The network helps show where Mark N. Stein may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark N. Stein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 245 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors Hit paper breakdown → | 2012 | 424 |
| 2 | 2016 | 291 | |
| 3 | 2010 | 241 | |
| 4 | 2017 | 224 | |
| 5 | 2009 | 208 | |
| 6 | Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial Hit paper breakdown → | 2021 | 189 |
| 7 | A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial Hit paper breakdown → | 2021 | 176 |
| 8 | 2017 | 166 | |
| 9 | 2012 | 126 | |
| 10 | 2018 | 122 | |
| 11 | 2010 | 119 | |
| 12 | 2019 | 117 | |
| 13 | 2009 | 108 | |
| 14 | 2013 | 91 | |
| 15 | 2015 | 87 | |
| 16 | 2008 | 86 | |
| 17 | 2016 | 77 | |
| 18 | 2019 | 66 | |
| 19 | 2014 | 64 | |
| 20 | 2018 | 63 |
About Mark N. Stein
Mark N. Stein is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 245 papers that have together received 6.0k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (59 papers), Cancer Immunotherapy and Biomarkers (57 papers), Renal cell carcinoma treatment (37 papers), Bladder and Urothelial Cancer Treatments (30 papers), Radiopharmaceutical Chemistry and Applications (21 papers), Cancer Treatment and Pharmacology (21 papers), Cancer Genomics and Diagnostics (20 papers) and Immunotherapy and Immune Responses (19 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (1.1k citations), Pulmonary and Respiratory Medicine (1.8k citations), Immunology (811 citations) and Molecular Biology (2.0k citations). Mark N. Stein has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Robert S. DiPaola, Eileen White, Susan Goodin, Kevin Bray, Grace L. Lu‐Yao, Charles G. Drake, Yu‐Hsuan Joni Shao, Simantini Eddy, Dmitri Dvorzhinski and Amit Mehta. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Annals of Oncology, Cancer Research and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.